Yide Mei
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Yide Mei has a total of 110 co-authors. Here are the top co-authors by number of shared publications:
- Fang Wang
School of Basic Medical Sciences, Anhui Medical University, Hefei, China
28 shared publications - Zhongyu Wang
Department of Thoracic Surgery, The First Affiliated Hospital of USTC, State Key Laboratory of Immune Response and Immunotherapy, Center for Advanced Interdisciplinary Science and Biomedicine of IHM, School of Basic Medical Sciences, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, China
22 shared publications - Jingjing Luo
Division of Life Sciences and Medicine, Center for Advanced Interdisciplinary Science and Biomedicine of IHM, Key Laboratory of Immune Response and Immunotherapy, School of Basic Medical Sciences, University of Science and Technology of China, Hefei, China
20 shared publications - Kaiyue Liu
Division of Life Sciences and Medicine, Center for Advanced Interdisciplinary Science and Biomedicine of IHM, Key Laboratory of Immune Response and Immunotherapy, School of Basic Medical Sciences, University of Science and Technology of China, Hefei, China
20 shared publications - Keyi Feng
School of Biological Sciences, University of Manchester, Manchester, United Kingdom
20 shared publications - Yang Yang
Division of Life Sciences and Medicine, Center for Advanced Interdisciplinary Science and Biomedicine of IHM, Key Laboratory of Immune Response and Immunotherapy, School of Basic Medical Sciences, University of Science and Technology of China, Hefei, China
20 shared publications
Latest Publications
- 21 July 2026
- Published by Springer Nature in Oncogene
- Vol. 45 (34) , 3572-3585
The RNA-binding protein RALY promotes ATM activation by stabilizing Tip60
- 21 July 2026
- Published by Springer Nature in Oncogene
- Vol. 45 (34) , 3572-3585
The RNA-binding protein RALY promotes ATM activation by stabilizing Tip60
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Figures S1 to S6, Table S1 and S2 from Energy Stress–Induced circEPB41(2) Promotes Lipogenesis in Hepatocellular Carcinoma
Figures S1 to S6, Table S1, and Table S2
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessFigures S1 to S6, Table S1 and S2 from Energy Stress–Induced circEPB41(2) Promotes Lipogenesis in Hepatocellular Carcinoma
Figures S1 to S6, Table S1, and Table S2
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Dataset 5 from Energy Stress–Induced circEPB41(2) Promotes Lipogenesis in Hepatocellular Carcinoma
Overlapping Genes with Decreased H3K9ac Deposition and Down-regulated Expression upon circEPB41(2) Knockdown
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Dataset 5 from Energy Stress–Induced circEPB41(2) Promotes Lipogenesis in Hepatocellular Carcinoma
Overlapping Genes with Decreased H3K9ac Deposition and Down-regulated Expression upon circEPB41(2) Knockdown
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Dataset 4 from Energy Stress–Induced circEPB41(2) Promotes Lipogenesis in Hepatocellular Carcinoma
List of H3K9ac Peaks in Control and circEPB41(2) Knockdown Cells
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Dataset 4 from Energy Stress–Induced circEPB41(2) Promotes Lipogenesis in Hepatocellular Carcinoma
List of H3K9ac Peaks in Control and circEPB41(2) Knockdown Cells
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Dataset 1 from Energy Stress–Induced circEPB41(2) Promotes Lipogenesis in Hepatocellular Carcinoma
The information of tissue samples from 73 liver cancer patients.
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Dataset 1 from Energy Stress–Induced circEPB41(2) Promotes Lipogenesis in Hepatocellular Carcinoma
The information of tissue samples from 73 liver cancer patients.
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Dataset 3 from Energy Stress–Induced circEPB41(2) Promotes Lipogenesis in Hepatocellular Carcinoma
Targeted lipidomics analysis in Control and circEPB41(2) knockdown cells
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Dataset 3 from Energy Stress–Induced circEPB41(2) Promotes Lipogenesis in Hepatocellular Carcinoma
Targeted lipidomics analysis in Control and circEPB41(2) knockdown cells
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Dataset 2 from Energy Stress–Induced circEPB41(2) Promotes Lipogenesis in Hepatocellular Carcinoma
Untargeted lipidomics analysis in Control and circEPB41(2) knockdown cells
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Dataset 2 from Energy Stress–Induced circEPB41(2) Promotes Lipogenesis in Hepatocellular Carcinoma
Untargeted lipidomics analysis in Control and circEPB41(2) knockdown cells
- 29 May 2026
- Published by Springer Nature in Cell Death & Differentiation
- p. 1-16
Akt-mediated RALY phosphorylation functions as a molecular switch governing c-Myc stability
The oncoprotein c-Myc is frequently dysregulated in human cancers, yet the underlying mechanisms remain elusive. Here, we identify the RNA-binding protein RALY as a critical post-translational stabilizer of c-Myc. RALY homodimerizes and acts as a scaffold to bridge the deubiquitinating enzyme USP22 to c-Myc, thereby preventing c-Myc ubiquitination and proteasomal degradation. Under physiological growth factor stimulation, RALY is phosphorylated by Akt at S106 and T160. This phosphorylation event enables ternary complex formation with USP22 and c-Myc, promoting c-Myc stabilization and driving RALY’s oncogenic activity. Furthermore, a synthetic peptide derived from RALY, termed RAMi, disrupts the RALY–USP22–c-Myc complex, destabilizes c-Myc, and exhibits potent anti-tumor effects. Together, these findings reveal Akt-mediated RALY phosphorylation as a molecular switch governing c-Myc stability and underscore the therapeutic potential of targeting the RALY–USP22–c-Myc axis in cancer. The alternative text for this image may have been generated using AI.
- 29 May 2026
- Published by Springer Nature in Cell Death & Differentiation
- p. 1-16
Akt-mediated RALY phosphorylation functions as a molecular switch governing c-Myc stability
The oncoprotein c-Myc is frequently dysregulated in human cancers, yet the underlying mechanisms remain elusive. Here, we identify the RNA-binding protein RALY as a critical post-translational stabilizer of c-Myc. RALY homodimerizes and acts as a scaffold to bridge the deubiquitinating enzyme USP22 to c-Myc, thereby preventing c-Myc ubiquitination and proteasomal degradation. Under physiological growth factor stimulation, RALY is phosphorylated by Akt at S106 and T160. This phosphorylation event enables ternary complex formation with USP22 and c-Myc, promoting c-Myc stabilization and driving RALY’s oncogenic activity. Furthermore, a synthetic peptide derived from RALY, termed RAMi, disrupts the RALY–USP22–c-Myc complex, destabilizes c-Myc, and exhibits potent anti-tumor effects. Together, these findings reveal Akt-mediated RALY phosphorylation as a molecular switch governing c-Myc stability and underscore the therapeutic potential of targeting the RALY–USP22–c-Myc axis in cancer. The alternative text for this image may have been generated using AI.
- Open Access
- 22 May 2026
- Published by Springer Nature in Cell Death Discovery
- Vol. 12 (1)
USP21 functions as an oncogenic regulator of the Mdm2-p53 axis in colorectal cancer
The tumor suppressor p53 is a pivotal guardian against tumorigenesis, with its activity primarily constrained by the ubiquitin E3 ligase Mdm2. However, the full complexity of the Mdm2-p53 regulatory network remains elusive. Here we report that the deubiquitinating enzyme USP21 physically interacts with and stabilizes Mdm2 in a deubiquitinase activity-independent manner. Mechanistically, USP21 acts as a scaffold to facilitate the USP7-Mdm2 interaction, enhancing Mdm2 stability and consequently promoting p53 ubiquitination and degradation. Functionally, USP21-mediated p53 suppression attenuates its tumor suppressive activity and accelerates colorectal cancer progression. Clinically, USP21 is upregulated in colorectal cancer tissues, and its elevated expression correlates with poor overall survival in patients with wild-type p53 tumors, but not in those with p53 mutations. These findings establish USP21 as an important regulator of the Mdm2-p53 axis and reveal its critical role in promoting colorectal carcinogenesis via p53 inhibition.
- 22 May 2026
- Published by Springer Nature in Cell Death Discovery
- Vol. 12 (1)
Open AccessUSP21 functions as an oncogenic regulator of the Mdm2-p53 axis in colorectal cancer
The tumor suppressor p53 is a pivotal guardian against tumorigenesis, with its activity primarily constrained by the ubiquitin E3 ligase Mdm2. However, the full complexity of the Mdm2-p53 regulatory network remains elusive. Here we report that the deubiquitinating enzyme USP21 physically interacts with and stabilizes Mdm2 in a deubiquitinase activity-independent manner. Mechanistically, USP21 acts as a scaffold to facilitate the USP7-Mdm2 interaction, enhancing Mdm2 stability and consequently promoting p53 ubiquitination and degradation. Functionally, USP21-mediated p53 suppression attenuates its tumor suppressive activity and accelerates colorectal cancer progression. Clinically, USP21 is upregulated in colorectal cancer tissues, and its elevated expression correlates with poor overall survival in patients with wild-type p53 tumors, but not in those with p53 mutations. These findings establish USP21 as an important regulator of the Mdm2-p53 axis and reveal its critical role in promoting colorectal carcinogenesis via p53 inhibition.
- Open Access
- 8 January 2026
- Published by Springer Nature in The EMBO Journal
- Vol. 45 (4) , 1109-1135
A non-canonical ARMS-GABARAP interaction modulates dendritic spine formation and synaptic development
ARMS (ankyrin repeat-rich membrane spanning) is a scaffold protein essential for neurotrophic signaling, synaptic development, and cytoskeletal remodeling. Despite its central role in neuronal function, how ARMS is regulated at the molecular level remains poorly understood. Here, we identify GABARAP, an Atg8-family autophagy adaptor, as a novel ARMS-binding protein that directly interacts with its N-terminal ankyrin repeats. We present the crystal structure of the ARMS-GABARAP complex, revealing an atypical interaction mode distinct from canonical LIR-dependent Atg8 interactions. Remarkably, ARMS specifically binds to the GABARAP subfamily of Atg8 proteins, setting it apart from the LC3 subfamily. Functional analysis demonstrates that GABARAP negatively regulates ARMS-mediated dendritic spine development and maturation in hippocampal neurons. Additionally, disrupting the ARMS-GABARAP complex using ankyrin-derived peptides alters ARMS subcellular localization, increasing its accumulation in the soma of neurons. Collectively, our findings uncover a novel ARMS-GABARAP interaction mechanism, establish the regulatory role of this complex in neuronal protein homeostasis, and suggest potential therapeutic strategies for targeting scaffold protein interactions in neurodevelopmental and neurodegenerative disorders.
- 8 January 2026
- Published by Springer Nature in The EMBO Journal
- Vol. 45 (4) , 1109-1135
Open AccessA non-canonical ARMS-GABARAP interaction modulates dendritic spine formation and synaptic development
ARMS (ankyrin repeat-rich membrane spanning) is a scaffold protein essential for neurotrophic signaling, synaptic development, and cytoskeletal remodeling. Despite its central role in neuronal function, how ARMS is regulated at the molecular level remains poorly understood. Here, we identify GABARAP, an Atg8-family autophagy adaptor, as a novel ARMS-binding protein that directly interacts with its N-terminal ankyrin repeats. We present the crystal structure of the ARMS-GABARAP complex, revealing an atypical interaction mode distinct from canonical LIR-dependent Atg8 interactions. Remarkably, ARMS specifically binds to the GABARAP subfamily of Atg8 proteins, setting it apart from the LC3 subfamily. Functional analysis demonstrates that GABARAP negatively regulates ARMS-mediated dendritic spine development and maturation in hippocampal neurons. Additionally, disrupting the ARMS-GABARAP complex using ankyrin-derived peptides alters ARMS subcellular localization, increasing its accumulation in the soma of neurons. Collectively, our findings uncover a novel ARMS-GABARAP interaction mechanism, establish the regulatory role of this complex in neuronal protein homeostasis, and suggest potential therapeutic strategies for targeting scaffold protein interactions in neurodevelopmental and neurodegenerative disorders.